quinacrine has been researched along with metyrapone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Aguila, MC; McCann, SM; Milenkovic, L; Snyder, GD | 1 |
| Fuchimoto, S; Orita, K; Shiiki, S | 1 |
| Rubanyi, GM; Vanhoutte, PM | 1 |
| Ioannides, C; Lewis, DF; Parke, DV | 1 |
| Johnston, MV; Supko, DE | 1 |
8 other study(ies) available for quinacrine and metyrapone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Growth Hormone-Releasing Hormone; Indomethacin; Kinetics; Lipoxygenase Inhibitors; Male; Masoprocol; Median Eminence; Metyrapone; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Rats, Inbred Strains; Somatostatin | 1990 |
A comparison of the antitumor effects of natural human tumor necrosis factors alpha and beta: the roles of arachidonic acid metabolism and intracellular cAMP.
Topics: Arachidonic Acid; Arachidonic Acids; Breast Neoplasms; Colforsin; Colonic Neoplasms; Cyclic AMP; Dexamethasone; Female; Humans; Indomethacin; Lymphotoxin-alpha; Metyrapone; Phospholipases A; Phospholipases A2; Quinacrine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
Nature of endothelium-derived relaxing factor: are there two relaxing mediators?
Topics: Acetylcholine; Animals; Arachidonic Acid; Arachidonic Acids; Biological Assay; Biological Products; Coronary Vessels; Cytochrome P-450 Enzyme Inhibitors; Dogs; Endothelium; Female; Lipoxygenase; Lipoxygenase Inhibitors; Male; Masoprocol; Metyrapone; Muscle Relaxation; Nitric Oxide; Phospholipases A; Phospholipases A2; Quinacrine | 1987 |
Molecular dimensions of the substrate binding site of cytochrome P-448.
Topics: Animals; Binding Sites; Computers; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochromes; Ellipticines; Enzyme Induction; Hydroxylation; Metyrapone; Models, Molecular; Proadifen; Protein Conformation; Quinacrine; Substrate Specificity | 1986 |
Dexamethasone potentiates NMDA receptor-mediated neuronal injury in the postnatal rat.
Topics: Aldosterone; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; Autoradiography; Blood Glucose; Brain; Dexamethasone; Electron Transport Complex IV; Glutamates; Glutamic Acid; Kainic Acid; Metyrapone; N-Methylaspartate; Neurotransmitter Agents; Quinacrine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1994 |